These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 28273003)

  • 61. "Tell Juliana": acceptability of the candidate microbicide VivaGel® and two placebo gels among ethnically diverse, sexually active young women participating in a phase 1 microbicide study.
    Carballo-Diéguez A; Giguere R; Dolezal C; Chen BA; Kahn J; Zimet G; Mabragaña M; Leu CS; McGowan I
    AIDS Behav; 2012 Oct; 16(7):1761-74. PubMed ID: 21863338
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Examining targets for HIV prevention: intravaginal practices in Urban Lusaka, Zambia.
    Alcaide ML; Chisembele M; Mumbi M; Malupande E; Jones D
    AIDS Patient Care STDS; 2014 Mar; 28(3):121-7. PubMed ID: 24568672
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Preferences and Acceptability of Vaginal Delivery Forms for HIV Prevention Among Women, Male Partners and Key Informants in South Africa and Zimbabwe: Qualitative Findings.
    Musara P; Milford C; Shapley-Quinn MK; Weinrib R; Mutero P; Odoom E; Mgodi NM; Chirenje ZM; Hanif H; Clark MR; Smit J; van der Straten A; Montgomery ET;
    AIDS Behav; 2021 Jan; 25(1):124-138. PubMed ID: 32588257
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The implications of post-coital intravaginal cleansing for the introduction of vaginal microbicides in South Africa.
    Gafos M; Pool R; Mzimela MA; Ndlovu HB; McCormack S; Elford J;
    AIDS Behav; 2014 Feb; 18(2):297-310. PubMed ID: 24337726
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Acceptability of a digital patient notification and linkage-to-care tool for French PrEPers (WeFLASH
    Lessard D; Aslan A; Zeggagh J; Morel S; Michels D; Lebouché B
    Int J STD AIDS; 2019 Dec; 30(14):1397-1407. PubMed ID: 31757193
    [No Abstract]   [Full Text] [Related]  

  • 66. Microbicides 2000 conference. Panel discussion: streamlining the process and regulatory issues. Microbicide research-streamlining the process.
    Cates W
    AIDS; 2001 Feb; 15 Suppl 1():S64-5. PubMed ID: 11403010
    [No Abstract]   [Full Text] [Related]  

  • 67. Charlene Susan Dezzutti (1964-2018) Virologist with a Passion for HIV Prevention.
    Hillier SL; Cummins JE; Rohan LC
    AIDS Res Hum Retroviruses; 2018 Jun; 34(6):475-476. PubMed ID: 29888975
    [No Abstract]   [Full Text] [Related]  

  • 68. This is a story about living-not dying.
    Ranscombe P
    Lancet HIV; 2018 Dec; 5(12):e686. PubMed ID: 30104179
    [No Abstract]   [Full Text] [Related]  

  • 69. Male partners of young women: assessing their attitudes toward topical microbicides.
    Auslander BA; Rupp RE; Short MB; Rosenthal SL
    J Adolesc Health; 2008 Jun; 42(6):626-8. PubMed ID: 18486872
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Young women's experience with using videoconferencing for the assessment of sexual behavior and microbicide use.
    Mabragaña M; Carballo-Diéguez A; Giguere R
    Telemed J E Health; 2013 Nov; 19(11):866-71. PubMed ID: 24050616
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Using integrated mixed methods to develop behavioral measures of factors associated with microbicide acceptability.
    Morrow KM; Rosen RK; Salomon L; Woodsong C; Severy L; Fava JL; Vargas S; Barroso C
    Qual Health Res; 2011 Jul; 21(7):987-99. PubMed ID: 21447804
    [TBL] [Abstract][Full Text] [Related]  

  • 72. HIV prevention through the lens of behavioral economics.
    Linnemayr S
    J Acquir Immune Defic Syndr; 2015 Apr; 68(4):e61-3. PubMed ID: 25559597
    [No Abstract]   [Full Text] [Related]  

  • 73. Women's solutioning and strategising in relation to their postpartum sexual health: A qualitative study.
    O'Malley D; Smith V; Higgins A
    Midwifery; 2019 Oct; 77():53-59. PubMed ID: 31255909
    [No Abstract]   [Full Text] [Related]  

  • 74. Report from the 16th Conference on Retroviruses and Opportunistic Infections. First (sort of) positive anti-HIV microbicide trial.
    del Rio C
    J Watch AIDS Clin Care; 2009 Apr; 21(4):34. PubMed ID: 19544618
    [No Abstract]   [Full Text] [Related]  

  • 75. Probiotics: the potential for a live microbicide to prevent HIV.
    Hemmerling A; Cohen CR
    J Acquir Immune Defic Syndr; 2011 Mar; 56(3):e98-101. PubMed ID: 21317584
    [No Abstract]   [Full Text] [Related]  

  • 76. Trends in microbicide formulations workshop.
    Friend DR
    Antiviral Res; 2010 Dec; 88 Suppl 1():S1-2. PubMed ID: 21109062
    [No Abstract]   [Full Text] [Related]  

  • 77. Dynamic partners: the state association and women's auxiliaries.
    CORDES DW; ENYART J
    Hospitals; 1953 Oct; 27(10):73-4; passim. PubMed ID: 13096060
    [No Abstract]   [Full Text] [Related]  

  • 78. Male engagement in women's microbicide use in Kenya: Navigating gender norms.
    Schuler SR; Bukusi E
    Health Care Women Int; 2017 May; 38(5):507-519. PubMed ID: 28273003
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Engaging male partners in women's microbicide use: evidence from clinical trials and implications for future research and microbicide introduction.
    Lanham M; Wilcher R; Montgomery ET; Pool R; Schuler S; Lenzi R; Friedland B
    J Int AIDS Soc; 2014; 17(3 Suppl 2):19159. PubMed ID: 25224618
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Male Partner Influence on Women's HIV Prevention Trial Participation and Use of Pre-exposure Prophylaxis: the Importance of "Understanding".
    Montgomery ET; van der Straten A; Stadler J; Hartmann M; Magazi B; Mathebula F; Laborde N; Soto-Torres L
    AIDS Behav; 2015 May; 19(5):784-93. PubMed ID: 25416076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.